Sonal Krishan1, Aparajita Pradhan2, and Shafi Kuchay3
1Radiology, Medanta Hospital, Gurgaon, India, 2Medanta Hospital, Gurgaon, India, 3Endocrinology, Medanta Hospital, Gurgaon, India
1Radiology, Medanta Hospital, Gurgaon, India, 2Medanta Hospital, Gurgaon, India, 3Endocrinology, Medanta Hospital, Gurgaon, India
In our prospective study, we recruited 25 with DM and 37 without DM. Subjects with DM
had nearly double the liver fat content
than those without diabetes
(12.1(8-20) Vs 6.7(4.2-10.7))(P= 0.004). Overall NAFLD
prevalence was 72.5%. MRI PDFF is an important tool in screening for NAFLD in diabetes.
Figure 1: Comparison of LFC assessed by MRI PDFF values among DM and
Non-DM. The mean LFC in DM group was 12.1 % (8-20) vs
Non-DM 6.7% (4.2-10.7).
Figure 2: Comparison of PFC assessed by MRI PDFF values among DM and Non- DM. The mean PFC in NAFLD subjects was 7.5% and in
Non NAFLD was 6.5%.
